登录 | 注册    关注公众号  
微信公众号
搜索
 >  Antibody>CD28 >CD8-M120b

Monoclonal Anti-Human CD28 Antibody, premium grade

GMP version GMP-MC2824 is now available for seamless transition.

抗体来源(Source)

Monoclonal Anti-Human CD28 Antibody, premium grade (CD8-M120b) is recombinantly produced from human 293 cells (HEK293).

It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
GMP-MC2824 is the GMP version of this CD8-M120b. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stag to later clinical phases.

亚型(Isotype)

Mouse IgG1 | Mouse Kappa

偶联(Conjugate)

Unconjugated

特异性(Specificity)

This product is a specific antibody specifically reacts with CD28.

内毒素(Endotoxin)

Less than 0.002 EU per μg by the LAL method.

蛋白A残留(Protein A)

<5 ppm of protein tested by ELISA.

宿主蛋白残留(Host Cell Protein)

<0.5 ng/μg of protein tested by ELISA.

宿主核酸残留(Host Cell DNA)

<0.02 ng/μg of protein tested by qPCR.

纯度(Purity)

>95% as determined by SDS-PAGE.

>95% as determined by SEC-MALS.

无菌(Sterility)

Negative

支原体(Mycoplasma)

Negative.

制剂(Formulation)

Supplied as 0.2 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

运输(Shipping)

This product is supplied and shipped with dry ice, please inquire the shipping cost.

存储(Storage)

For long term storage, the product should be stored at liquid state at -70°C.

This product is stable after storage at:

  1. 2-8°C for 12 months under sterile condition;
  2. -70°C for 24 months.

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
 

电泳(SDS-PAGE)

CD28 SDS-PAGE

Monoclonal Anti-Human CD28 Antibody, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS

CD28 SEC-MALS

The purity of Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) is more than 95% and the molecular weight of this protein is around 140-160 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-CELL BASE

CD28 CELL

Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) stimulates secretion of IL-2 by PBMC stimulated with 4 ng/mL Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3), premium grade (Cat. No. CDE-M120a). The typically EC50 for this effect is 2.03 ng/mL (QC tested).

Protocol

CD28 CELL

The cell activity of Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) is 3.7 times better than competitor.

Protocol

 

稳定性(Stability)

CD28 STABILITY

The Cell based assay shows batch-to-batch consistency between Acro's GMP and PG CD28 Antibody.

 

活性(Bioactivity)-ELISA

CD28 ELISA

Immobilized Human / Cynomolgus / Rhesus macaque CD28, His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) with a linear range of 0.098-1.563 ng/mL (QC tested).

Protocol

 
评论(8)
  1. 151XXXXXXX5
  2. 1人赞
  3. 经过实验室小伙伴的推荐,通过对后续实验结果的跟踪发现该产品在结果上有很强的对比力,为我后续的实验提供了很好的依据,推动了项目的进行!!
  4. 2023-2-13
  1. 138XXXXXXX4
  2. 0人赞
  3. 一直用的购买A c r o家蛋白,产品质量和售后服务一如既往的好,这个蛋白用作结合力筛选,信号值稳定,检测结果符合预期,以后还会继续关注。
  4. 2023-2-17
  1. 133XXXXXXX3
  2. 0人赞
  3. 技术服务售前比较专业,沟通顺利,产品质量也比较稳定,稳定性较好,售后服务也比较完善,及时回复,物流也较快,有问题能及时沟通
  4. 2023-2-17
 
ACRO质量管理体系
 
 

背景(Background)

T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.

 

前沿进展

Revealing the effects of various immune cells in anorexia nervosa: Evidence from Mendelian randomization
Deng, Yu, Yin et al
Medicine (Baltimore) (2025) 104 (12), e41817
Abstract: The aim of this study was to assess the causal relationship between immune cells and anorexia nervosa (AN) by Mendelian randomization (MR). Data on immune cell phenotypes and AN were obtained from genome-wide association studies. Next, single nucleotide polymorphisms included in the MR analysis were screened according the basic assumptions. Furthermore, inverse variance weighted was used as the main method for MR analysis to evaluate the causal effect of immune cell phenotypes on AN. Finally, MR-Egger intercept, Cochran Q, and leave-one-out sensitivity analyses were used to assess horizontal pleiotropy, heterogeneity, and robustness, respectively. The MR analysis showed that NKT %lymphocyte (OR 1.201, 95% CI = 1.021-1.411, P = .027), NKT %T cell (OR 1.258, 95%CI 1.043-1.519, P = .017), double negative (DN) (CD4-CD8-) NKT %lymphocyte (OR 1.235, 95%CI 1.074-1.420, P = .003), DN (CD4-CD8-) NKT %T cell (OR 1.222, 95%CI 1.060-1.410, P = .006), CD8dim NKT absolute count (OR 1.225, 95%CI 1.045-1.436, P = .012), CD8dim NKT %lymphocyte (OR 1.214, 95%CI 1.043-1.414, P = .012), CD8dim NKT %T cell (OR 1.215, 95%CI 1.035-1.425, P = .017), CD16-CD56 on NKT (OR 1.193, 95%CI 1.014-1.402, P = .033), CD28 + CD45RA + CD8br %T cell (OR 1.020, 95%CI 1.002-1.037, P = .025) were associated with increased genetic susceptibility to AN. MR-Egger showed no horizontal pleiotropy (P ≥ .05). Cochran Q and sensitivity analysis showed that the results were not heterogeneous and were robust. This MR analysis revealed 9 immune cell phenotypes related to increased genetic susceptibility to AN, emphasizing the importance of NKT and CD8 in AN. This finding provides new insights for understanding the pathogenesis of AN and developing immune-targeted drugs.Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Genetic and Epigenetic Changes in Melanoma Progression: A TCGA-based Study
Cakir, Lebe, Toper et al
Appl Immunohistochem Mol Morphol (2025)
Abstract: We aimed to investigate molecular mechanisms affecting melanoma progression by comparing genetic/epigenetic features between melanomas of different Breslow thickness and stage using TCGA (The Cancer Genome Atlas) data. The TCGA, Firehose Legacy, melanoma data set was utilized on the cBioPortal website. The cases were compared in terms of mRNA expression and DNA methylation. Gene Ontology (GO) and KEGG pathways enrichment analysis were performed using the online WebGestalt tool. STRING and Cytoscape software were used to construct a protein-protein interaction network and identify hub genes. P and q<0.05, FDR< 0.05 were considered statistically significant. 1001 differentially expressed genes were identified between thin (≤1 mm) and thick (>1 mm) melanomas. Pathway analyses revealed that genes enriched in thin melanomas were associated with adaptive immune response, T-cell activation, immune response regulation, leukocyte, and cytokine-related pathways, whereas genes enriched in thick melanomas were related to epidermis development. Ten hub genes were identified (CD4, IFNG, PTPRC, CD8A, CTLA4, CD69, ICOS, CD27, CD28, CD19). All of these genes are involved in crucial immunological processes. Understanding the complex changes in melanoma progression is essential for accurate diagnosis and prediction of prognosis. Our results may shed light on subsequent studies to identify the steps in melanoma progression.Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Donaubauer, Schäfer, Hundsdorfer et al
J Vis Exp (2025)
Abstract: Cytotoxic T cells play a key role in the elimination of tumor cells and are, therefore, intensively studied in cancer immunology. The frequency and activity of cytotoxic T cells within tumors and their tumor microenvironment (TME) are now well-established prognostic and predictive biomarkers for numerous tumor types. However, it is well-known that various tumor treatment modalities, including radiotherapy, chemotherapy, immunotherapy, and targeted therapy, modulate not only the immunogenicity of the tumor but also the immune system itself. Consequently, the interaction between tumor cells and T cells requires more intensive study in different therapeutic contexts to fully understand the complex role of T cells during tumor therapy. To address this need, a protocol was developed to analyze the activity and proliferative capacity of human cytotoxic (CD8+) T cells in co-culture with pre-treated tumor cells. Specifically, CD8+ T cells from healthy donors are stained with the non-toxic proliferation marker carboxyfluorescein diacetate succinimidyl ester (CFSE) and stimulated using CD3/CD28-coated plates. Subsequently, T cells are co-cultured with pre-treated tumor cells. As a readout, T cell proliferation is quantified by measuring CFSE signal distribution and assessing the expression of surface activation markers via flow cytometry. This can be further complemented by quantifying cytokine release using enzyme-linked immunosorbent assay (ELISA). This method facilitates the evaluation of treatment-induced changes in the interaction between tumor cells and T cells, providing a foundation for more detailed analyses of tumor treatment modalities and their immunogenicity in a human ex vivo setting. Additionally, it contributes to the reduction of pre-clinical in vivo analyses.
Unveiling Potential Blood Markers for Endometriosis Through the Integration and Experimental Validation of Immune Cell Traits Genome and Genome-Wide Associated Data
Mei, Jiang, Zhang et al
Int J Womens Health (2025) 17, 845-853
Abstract: While endometriosis (EM) has been previously associated with multiple immune factors, the causal relationship underlying these associations remains unclear.In this study, Two-sample Mendelian randomization (MR) method was employed to investigate the causal relationship between 731 immune cell traits and EM based on tabulated data from genome-wide association studies (GWAS).MR method includes inverse variance weighting (IVW), the weighted median (WM), MR-Egger, the weighted model, and the simple model. IVW is used as the primary method for judging causal effects. Peripheral blood was obtained from EM patients, and the positive immune cell phenotype was confirmed using flow cytometry.After P-value correction, our two-sample MR showed that CD28 on CD28+ DN (CD4-CD8-) had a suggestive causal relationship with EM (β =0.040, 95% CI =1.02-1.06, P =0.00029, PFDR = 0.1984). The results of the other two main methods were similar: Weighted median (OR =1.031, 95% CI =1.00-1.07, P =0.082); MR-Egger (OR =1.032, 95% CI =1.10-1.06, P =0.044). The flow cytometry results indicated that the expression level of CD28 on CD28+ DN (CD4-CD-8) was significantly increased in the ectopic intima of EM patients.Our study demonstrated a causal relationship between immune traits and EM, and the results were verified by clinical samples. The study may provide new biomarkers for the early diagnosis and immunotherapy of EM.© 2025 Mei et al.
Showing 1-4 of 13833 papers.
Powered by BizGenius
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CD28靶点信息
英文全称:T-cell-specific surface glycoprotein CD28
中文全称:T细胞特异性表面糖蛋白CD28
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:25详情
最高研发阶段:临床二期
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定